Commerzbank Ag set a €25.00 ($29.76) target price on Rhoen Klinikum AG (ETR:RHK) in a research report released on Monday morning. The brokerage currently has a neutral rating on the stock.

Other analysts have also issued reports about the company. Berenberg Bank set a €26.00 ($30.95) price target on Rhoen Klinikum AG and gave the company a neutral rating in a research note on Tuesday, August 1st. Deutsche Bank AG set a €21.00 ($25.00) price target on Rhoen Klinikum AG and gave the company a neutral rating in a research note on Wednesday, July 26th. Baader Bank set a €24.00 ($28.57) price target on Rhoen Klinikum AG and gave the company a neutral rating in a research note on Thursday, June 8th. Independent Research GmbH set a €28.00 ($33.33) price target on Rhoen Klinikum AG and gave the company a neutral rating in a research note on Monday, August 14th. Finally, Warburg Research set a €26.00 ($30.95) price target on Rhoen Klinikum AG and gave the company a neutral rating in a research note on Thursday, August 3rd. Three analysts have rated the stock with a sell rating and six have issued a hold rating to the company. The company presently has an average rating of Hold and a consensus price target of €24.06 ($28.65).

Shares of Rhoen Klinikum AG (ETR RHK) opened at 28.299 on Monday. Rhoen Klinikum AG has a one year low of €22.91 and a one year high of €28.67. The company has a market capitalization of €1.89 billion and a PE ratio of 442.172. The firm’s 50-day moving average price is €27.54 and its 200 day moving average price is €26.33.

COPYRIGHT VIOLATION NOTICE: “Rhoen Klinikum AG (RHK) Given a €25.00 Price Target by Commerzbank Ag Analysts” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/19/rhoen-klinikum-ag-rhk-given-a-25-00-price-target-by-commerzbank-ag-analysts.html.

About Rhoen Klinikum AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Stock Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related stocks with our FREE daily email newsletter.